Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-02-06 @ 7:18 AM
Study NCT ID:
NCT01008150
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2009-11-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |